company background image
INSP logo

Inspire Medical Systems NYSE:INSP Stock Report

Last Price

US$158.79

Market Cap

US$4.6b

7D

0.04%

1Y

-48.7%

Updated

31 May, 2024

Data

Company Financials +

Inspire Medical Systems, Inc.

NYSE:INSP Stock Report

Market Cap: US$4.6b

INSP Stock Overview

A medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally.

INSP fundamental analysis
Snowflake Score
Valuation5/6
Future Growth4/6
Past Performance0/6
Financial Health6/6
Dividends0/6

Inspire Medical Systems, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Inspire Medical Systems
Historical stock prices
Current Share PriceUS$158.79
52 Week HighUS$330.00
52 Week LowUS$123.27
Beta1.35
1 Month Change-34.92%
3 Month Change-13.48%
1 Year Change-48.73%
3 Year Change-3.72%
5 Year Change180.60%
Change since IPO535.67%

Recent News & Updates

Inspire Medical Systems, Inc.'s (NYSE:INSP) Stock Retreats 28% But Revenues Haven't Escaped The Attention Of Investors

May 09
Inspire Medical Systems, Inc.'s (NYSE:INSP) Stock Retreats 28% But Revenues Haven't Escaped The Attention Of Investors

Inspire Medical Systems: A Potential Example Of Market Mispricing

Apr 05

Recent updates

Inspire Medical Systems, Inc.'s (NYSE:INSP) Stock Retreats 28% But Revenues Haven't Escaped The Attention Of Investors

May 09
Inspire Medical Systems, Inc.'s (NYSE:INSP) Stock Retreats 28% But Revenues Haven't Escaped The Attention Of Investors

Inspire Medical Systems: A Potential Example Of Market Mispricing

Apr 05

Inspire Medical Systems, Inc. (NYSE:INSP) Shares Could Be 23% Below Their Intrinsic Value Estimate

Mar 27
Inspire Medical Systems, Inc. (NYSE:INSP) Shares Could Be 23% Below Their Intrinsic Value Estimate

Is There Now An Opportunity In Inspire Medical Systems, Inc. (NYSE:INSP)?

Mar 06
Is There Now An Opportunity In Inspire Medical Systems, Inc. (NYSE:INSP)?

Inspire Medical: A Good Night Sleep

Feb 08

Inspire Medical Systems, Inc.'s (NYSE:INSP) 35% Jump Shows Its Popularity With Investors

Dec 26
Inspire Medical Systems, Inc.'s (NYSE:INSP) 35% Jump Shows Its Popularity With Investors

Inspire Medical Systems: Time To Wake Up

Nov 17

An Intrinsic Calculation For Inspire Medical Systems, Inc. (NYSE:INSP) Suggests It's 38% Undervalued

Nov 13
An Intrinsic Calculation For Inspire Medical Systems, Inc. (NYSE:INSP) Suggests It's 38% Undervalued

Inspire Medical Systems: Stock In A Deep Sleep Despite Stellar Sales Growth

Oct 25

When Should You Buy Inspire Medical Systems, Inc. (NYSE:INSP)?

Sep 05
When Should You Buy Inspire Medical Systems, Inc. (NYSE:INSP)?

Inspire Medical Systems: Excellent Execution And Reset Valuation

Aug 17

Does This Valuation Of Inspire Medical Systems, Inc. (NYSE:INSP) Imply Investors Are Overpaying?

Aug 10
Does This Valuation Of Inspire Medical Systems, Inc. (NYSE:INSP) Imply Investors Are Overpaying?

Inspire Medical Systems: Revolutionizing Obstructive Sleep Apnea Treatment

Jul 19

Inspire Medical Systems, Inc. (NYSE:INSP) Not Lagging Industry On Growth Or Pricing

Jul 16
Inspire Medical Systems, Inc. (NYSE:INSP) Not Lagging Industry On Growth Or Pricing

Inspire Medical Systems: Valuation, Sentiment, Fundamental Factors Call For Re-Rating

Jun 15

Why Inspire Medical Systems, Inc. (NYSE:INSP) Could Be Worth Watching

May 06
Why Inspire Medical Systems, Inc. (NYSE:INSP) Could Be Worth Watching

Inspire Medical stock rises after guiding revenue above estimates

Jan 09

Inspire Medical nears eight-month high as KeyBanc issues bullish call

Dec 13

Inspire Medical Systems: Sleep Apnea Equipment - Today's Best Stock Buy

Oct 26

Inspire Medical Systems: Sleep Apnea Value Delivery Pocket

Oct 13

Inspire Medical Systems prices 1M of stock offering at $215.00/share

Aug 12

Inspire Medical Systems GAAP EPS of -$0.53 beats by $0.07, revenue of $91.4M beats by $13.34M

Aug 02

Inspire Medical gets FDA nod for full-body MRI compatibility with Inspire therapy

Jul 06

Inspire Medical Systems Priced Low In Past-Year Repeated Range

May 12

Shareholder Returns

INSPUS Medical EquipmentUS Market
7D0.04%-1.2%-1.2%
1Y-48.7%1.8%21.5%

Return vs Industry: INSP underperformed the US Medical Equipment industry which returned 1.8% over the past year.

Return vs Market: INSP underperformed the US Market which returned 21.5% over the past year.

Price Volatility

Is INSP's price volatile compared to industry and market?
INSP volatility
INSP Average Weekly Movement11.8%
Medical Equipment Industry Average Movement7.8%
Market Average Movement5.8%
10% most volatile stocks in US Market15.6%
10% least volatile stocks in US Market2.9%

Stable Share Price: INSP's share price has been volatile over the past 3 months.

Volatility Over Time: INSP's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of US stocks.

About the Company

FoundedEmployeesCEOWebsite
20071,011Tim Herbertwww.inspiresleep.com

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient’s breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway.

Inspire Medical Systems, Inc. Fundamentals Summary

How do Inspire Medical Systems's earnings and revenue compare to its market cap?
INSP fundamental statistics
Market capUS$4.59b
Earnings (TTM)-US$15.73m
Revenue (TTM)US$660.91m

7.1x

P/S Ratio

-299.8x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
INSP income statement (TTM)
RevenueUS$660.91m
Cost of RevenueUS$101.45m
Gross ProfitUS$559.47m
Other ExpensesUS$575.20m
Earnings-US$15.73m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-0.53
Gross Margin84.65%
Net Profit Margin-2.38%
Debt/Equity Ratio0%

How did INSP perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.